BioCardia, Inc. (BCDA) stock
BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.79−0.00 (-0.24%)
Close on Nov 17, 2026Market cap $11.93MP/E –Yield –
BioCardia total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioCardia's total debt was $225.00K at Sep 30, 2020.
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | $225.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $281.00K | – |
See a number that looks wrong?